![Frontiers | Prevalence of adverse events during ticagrelor versus clopidogrel treatment and its association with premature discontinuation of dual antiplatelet therapy in East Asian patients with acute coronary syndrome Frontiers | Prevalence of adverse events during ticagrelor versus clopidogrel treatment and its association with premature discontinuation of dual antiplatelet therapy in East Asian patients with acute coronary syndrome](https://www.frontiersin.org/files/Articles/1053867/fcvm-09-1053867-HTML/image_m/fcvm-09-1053867-g000.jpg)
Frontiers | Prevalence of adverse events during ticagrelor versus clopidogrel treatment and its association with premature discontinuation of dual antiplatelet therapy in East Asian patients with acute coronary syndrome
![PDF) Switching Ticagrelor to 600 mg or 300 mg Clopidogrel Loading Bridge in Patients with Unstable Angina PDF) Switching Ticagrelor to 600 mg or 300 mg Clopidogrel Loading Bridge in Patients with Unstable Angina](https://www.researchgate.net/profile/Sinem-Cakal/publication/352070870/figure/fig1/AS:1030440756465664@1622687629909/Algorithm-for-switching-between-oral-P2Y12-inhibitors-in-the-acute-setting-LD-loading_Q320.jpg)
PDF) Switching Ticagrelor to 600 mg or 300 mg Clopidogrel Loading Bridge in Patients with Unstable Angina
![Recomendaciones del manejo antiagregante en Cardiología. Documento de revisión de la Sociedad Andaluza de Cardiología | Cardiocore Recomendaciones del manejo antiagregante en Cardiología. Documento de revisión de la Sociedad Andaluza de Cardiología | Cardiocore](https://multimedia.elsevier.es/PublicationsMultimediaV1/file//1889898X/0000005300000004/v1_201811090635/S1889898X18300525/v1_201811090635/es/main.assets/gr6.jpeg?xkr=ue/ImdikoIMrsJoerZ+w997EogCnBdOOD93cPFbanNfl7PCMXrJwadRIy73noQ6gapZtgzIBRd3adc4VdUv3oiL9QnE3SsUG2wXe01LezFvL1ygxPSPBOTWxf/4AUtAW/WLGoYUVCmip74RUCOtFwfQEtp3VFvZPiUMK37eSKviJrePmYf0cl1gz+fXL1Rc4T+2MFkPtbbnfFP67zZNKcf6Njr/eogKHXmHLuSm0m0FjOfYeOVVo+e3+hS0cUtgD7JY16Xr7Hy1iw2/7MorWLFoLvMePYXipck77iKObrEE=)
Recomendaciones del manejo antiagregante en Cardiología. Documento de revisión de la Sociedad Andaluza de Cardiología | Cardiocore
![Dr. Sheila Sahni on X: "Algorithm for switching between oral P2Y12 inhibitors in the acute and chronic setting. (For the Figure: LD = loading dose; MD = maintenance dose) Source: 2017 ESC Dr. Sheila Sahni on X: "Algorithm for switching between oral P2Y12 inhibitors in the acute and chronic setting. (For the Figure: LD = loading dose; MD = maintenance dose) Source: 2017 ESC](https://pbs.twimg.com/media/DolJmHqUwAEInrl.jpg:large)
Dr. Sheila Sahni on X: "Algorithm for switching between oral P2Y12 inhibitors in the acute and chronic setting. (For the Figure: LD = loading dose; MD = maintenance dose) Source: 2017 ESC
![Pharmacodynamic profiles of switching from ticagrelor to clopidogrel... | Download Scientific Diagram Pharmacodynamic profiles of switching from ticagrelor to clopidogrel... | Download Scientific Diagram](https://www.researchgate.net/publication/323693640/figure/fig4/AS:930564282523659@1598875222973/Pharmacodynamic-profiles-of-switching-from-ticagrelor-to-clopidogrel-measured-by.png)
Pharmacodynamic profiles of switching from ticagrelor to clopidogrel... | Download Scientific Diagram
![Pharmacodynamic Effects of Switching From Ticagrelor to Clopidogrel in Patients With Coronary Artery Disease | Circulation Pharmacodynamic Effects of Switching From Ticagrelor to Clopidogrel in Patients With Coronary Artery Disease | Circulation](https://www.ahajournals.org/cms/asset/6f83caaa-7e34-49ab-ad81-17ae041f9bca/2450fig01.gif)
Pharmacodynamic Effects of Switching From Ticagrelor to Clopidogrel in Patients With Coronary Artery Disease | Circulation
![Switching P2Y12-receptor inhibitors in patients with coronary artery disease | Nature Reviews Cardiology Switching P2Y12-receptor inhibitors in patients with coronary artery disease | Nature Reviews Cardiology](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fnrcardio.2015.113/MediaObjects/41569_2016_Article_BFnrcardio2015113_Fig8_HTML.jpg)
Switching P2Y12-receptor inhibitors in patients with coronary artery disease | Nature Reviews Cardiology
![JCM | Free Full-Text | Switching Ticagrelor to 600 mg or 300 mg Clopidogrel Loading Bridge in Patients with Unstable Angina JCM | Free Full-Text | Switching Ticagrelor to 600 mg or 300 mg Clopidogrel Loading Bridge in Patients with Unstable Angina](https://www.mdpi.com/jcm/jcm-10-02463/article_deploy/html/images/jcm-10-02463-g001-550.jpg)
JCM | Free Full-Text | Switching Ticagrelor to 600 mg or 300 mg Clopidogrel Loading Bridge in Patients with Unstable Angina
![Editor's Corner | DAPT, Our Genome and Clopidogrel "Resistance": Are We Near an Answer to "Which Drug, When?" - American College of Cardiology Editor's Corner | DAPT, Our Genome and Clopidogrel "Resistance": Are We Near an Answer to "Which Drug, When?" - American College of Cardiology](http://www.acc.org//-/media/Non-Clinical/Images/Membership/Member-Benefits-and-Resources/Member-Publications/Cardiology-Interventions/2018/May-June/Editors-Corner-1.jpg)
Editor's Corner | DAPT, Our Genome and Clopidogrel "Resistance": Are We Near an Answer to "Which Drug, When?" - American College of Cardiology
![Ticagrelor versus clopidogrel in acute myocardial infarction patients with multivessel disease; From Korea Acute Myocardial Infarction Registry-National Institute of Health - ScienceDirect Ticagrelor versus clopidogrel in acute myocardial infarction patients with multivessel disease; From Korea Acute Myocardial Infarction Registry-National Institute of Health - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0914508719303430-gr1.jpg)
Ticagrelor versus clopidogrel in acute myocardial infarction patients with multivessel disease; From Korea Acute Myocardial Infarction Registry-National Institute of Health - ScienceDirect
![R Ladeiras Lopes on X: "Keep these slides at hand: how to switch between the second antiplatelet agent (clopidogrel, ticagrelor and prasugrel) in the acute vs the chronic setting? Nice talk by R Ladeiras Lopes on X: "Keep these slides at hand: how to switch between the second antiplatelet agent (clopidogrel, ticagrelor and prasugrel) in the acute vs the chronic setting? Nice talk by](https://pbs.twimg.com/media/DpUoBieV4AACssW.jpg)
R Ladeiras Lopes on X: "Keep these slides at hand: how to switch between the second antiplatelet agent (clopidogrel, ticagrelor and prasugrel) in the acute vs the chronic setting? Nice talk by
International Expert Consensus on Switching Platelet P2Y<sub>12</sub> Receptorâ•fiInhibiting Therapies
![Ticagrelor plus aspirin versus clopidogrel plus aspirin for platelet reactivity in patients with minor stroke or transient ischaemic attack: open label, blinded endpoint, randomised controlled phase II trial | The BMJ Ticagrelor plus aspirin versus clopidogrel plus aspirin for platelet reactivity in patients with minor stroke or transient ischaemic attack: open label, blinded endpoint, randomised controlled phase II trial | The BMJ](https://www.bmj.com/content/bmj/365/bmj.l2211/F1.medium.jpg)
Ticagrelor plus aspirin versus clopidogrel plus aspirin for platelet reactivity in patients with minor stroke or transient ischaemic attack: open label, blinded endpoint, randomised controlled phase II trial | The BMJ
![JCDD | Free Full-Text | Dual Antiplatelet Therapy with Parenteral P2Y12 Inhibitors: Rationale, Evidence, and Future Directions JCDD | Free Full-Text | Dual Antiplatelet Therapy with Parenteral P2Y12 Inhibitors: Rationale, Evidence, and Future Directions](https://pub.mdpi-res.com/jcdd/jcdd-10-00163/article_deploy/html/images/jcdd-10-00163-g001.png?1681027713)
JCDD | Free Full-Text | Dual Antiplatelet Therapy with Parenteral P2Y12 Inhibitors: Rationale, Evidence, and Future Directions
![Pharmacodynamic profiles of switching from ticagrelor to clopidogrel... | Download Scientific Diagram Pharmacodynamic profiles of switching from ticagrelor to clopidogrel... | Download Scientific Diagram](https://www.researchgate.net/publication/323693640/figure/fig3/AS:930564282519571@1598875222900/Pharmacodynamic-profiles-of-switching-from-ticagrelor-to-clopidogrel-measured-by.png)
Pharmacodynamic profiles of switching from ticagrelor to clopidogrel... | Download Scientific Diagram
![Algorithm for switching between oral P2Y12 inhibitors in the acute and... | Download Scientific Diagram Algorithm for switching between oral P2Y12 inhibitors in the acute and... | Download Scientific Diagram](https://www.researchgate.net/publication/340650809/figure/fig2/AS:880587086761986@1586959730471/Algorithm-for-switching-between-oral-P2Y12-inhibitors-in-the-acute-and-chronic-setting.png)
Algorithm for switching between oral P2Y12 inhibitors in the acute and... | Download Scientific Diagram
![JCM | Free Full-Text | Switching Ticagrelor to 600 mg or 300 mg Clopidogrel Loading Bridge in Patients with Unstable Angina JCM | Free Full-Text | Switching Ticagrelor to 600 mg or 300 mg Clopidogrel Loading Bridge in Patients with Unstable Angina](https://pub.mdpi-res.com/jcm/jcm-10-02463/article_deploy/html/images/jcm-10-02463-g002.png?1622622676)
JCM | Free Full-Text | Switching Ticagrelor to 600 mg or 300 mg Clopidogrel Loading Bridge in Patients with Unstable Angina
![Half‐Dose (45 mg Twice Daily) Ticagrelor Versus Clopidogrel in Neuroendovascular Dual Antiplatelet Therapy: A Single‐Center Cohort Study | Stroke: Vascular and Interventional Neurology Half‐Dose (45 mg Twice Daily) Ticagrelor Versus Clopidogrel in Neuroendovascular Dual Antiplatelet Therapy: A Single‐Center Cohort Study | Stroke: Vascular and Interventional Neurology](https://www.ahajournals.org/cms/asset/72916ca7-0636-4808-8981-1a926a234009/svi212369-gra-0001.png)
Half‐Dose (45 mg Twice Daily) Ticagrelor Versus Clopidogrel in Neuroendovascular Dual Antiplatelet Therapy: A Single‐Center Cohort Study | Stroke: Vascular and Interventional Neurology
![Switching mode between the P2Y 12 platelet receptor inhibitors, acute... | Download Scientific Diagram Switching mode between the P2Y 12 platelet receptor inhibitors, acute... | Download Scientific Diagram](https://www.researchgate.net/publication/325532292/figure/fig6/AS:634833571172352@1528367526064/Switching-mode-between-the-P2Y-12-platelet-receptor-inhibitors-acute-and-chronic-phase.png)
Switching mode between the P2Y 12 platelet receptor inhibitors, acute... | Download Scientific Diagram
![mandeep singh on X: "Switching P2Y12 after PCI: 1. Wait 24h except Clopidogrel (C) to ticagrelor (T)/Prasugrel (P). 2. Give loading dose <30d and maintenance dose after except T to P/C switch: mandeep singh on X: "Switching P2Y12 after PCI: 1. Wait 24h except Clopidogrel (C) to ticagrelor (T)/Prasugrel (P). 2. Give loading dose <30d and maintenance dose after except T to P/C switch:](https://pbs.twimg.com/media/FONl3xoXIAU2Z64.jpg:large)